Viewing StudyNCT00026208



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00026208
Status: COMPLETED
Last Update Posted: 2018-07-24
First Post: 2001-11-09

Brief Title: Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkins Lymphoma
Sponsor: Stanford University
Organization: Stanford University

Organization Data

Organization: Stanford University
Class: OTHER
Study ID: IRB-13081
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Stanford University
Lead Sponsor Class: OTHER
Responsible Party: Ranjana Advani
Responsible Party Title: Saul A Rosenberg MD Professor of Lymphoma
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Stanford University
Old Name: None
Old Organization: None

Collaborators